Abstract

Postpartum depression (PPD) is a prevalent and complex mental health condition that affects a significant number of mothers worldwide. Unlike the transient mood swings commonly experienced after childbirth, PPD is characterized by persistent and debilitating symptoms, encompassing emotional, cognitive, and physical domains. The onset of PPD typically occurs within the first few weeks to months following delivery, posing challenges to maternal well-being and impacting the mother-infant relationship. Several risk factors contribute to the development of PPD, including a history of mental health disorders, insufficient social support, and hormonal fluctuations associated with childbirth. The hormonal changes, particularly the rapid decline in estrogen and progesterone levels, are believed to play a role in the pathogenesis of PPD. However, the etiology is multifaceted, involving a complex interplay of biological, psychological, and environmental factors. Recognizing the symptoms of PPD is crucial for early intervention and effective management. Symptoms may include persistent feelings of sadness, hopelessness, irritability, disturbances in sleep and appetite, and difficulties bonding with the infant. Timely diagnosis and appropriate treatment modalities, such as psychotherapy, support groups, and pharmacotherapy, can significantly improve outcomes. This abstract emphasizes the importance of raising awareness about PPD, destigmatizing mental health issues surrounding childbirth, and fostering a supportive environment for affected mothers. Healthcare professionals, family, and friends play pivotal roles in identifying and addressing PPD, ensuring the well-being of both mothers and their infants. Comprehensive and compassionate care is essential to mitigate the impact of PPD on maternal mental health and promote a positive postpartum experience.

Keywords

Post Partum Depression(PPD), mother-infant relationship, hormonal fluctuations, treatment modalities, psychotherapy, comprehensive and compassionate care, maternal mental health.

Introduction

Depression, a pervasive and often misunderstood mental health condition, affects millions of people worldwide. Its impact extends far beyond the individual, touching the lives of families, friends, and communities. In this article, we will delve into the multifaceted nature of depression, exploring its various forms, causes, symptoms, and potential treatments. By shedding light on the complexities of depression, we hope to foster greater understanding, empathy, and support for those grappling with this silent but profound struggle.

Depression is not just a passing bout of sadness; it is a pervasive and prolonged state of low mood that significantly disrupts one's daily life. Classified as a mood disorder, depression manifests in various forms, ranging from major depressive disorder (MDD) and persistent depressive disorder (PDD) to seasonal affective disorder (SAD) and bipolar disorder.[1-2]

The Many Faces of Depression

1. Major Depressive Disorder (MDD):

MDD, commonly referred to as clinical depression, is characterized by persistent feelings of sadness, hopelessness, and a lack of interest in activities that once brought joy. Individuals with MDD often struggle with disrupted sleep patterns, changes in appetite, and difficulty concentrating.[3-4]

2. Persistent Depressive Disorder (PDD):

PDD, also known as dysthymia, is a chronic form of depression lasting for two years or more. While its symptoms may be less severe than MDD, PDD can still have a profound impact on one's quality of life, leading to long-term emotional suffering.[5-6]

3. Seasonal Affective Disorder (SAD):

SAD is a type of depression linked to changes in seasons, particularly the reduction of sunlight during the winter months. Individuals with SAD may experience lethargy, oversleeping, and weight gain during this period, with symptoms subsiding as sunlight exposure increases.[7-8]

4. Bipolar Disorder:

Bipolar disorder involves alternating episodes of depression and mania. During manic episodes, individuals may feel excessively energetic, impulsive, and have an inflated sense of self-esteem. The unpredictable shifts between depressive and manic states make bipolar disorder a unique and challenging form of depression.[9-10]

Understanding the Causes:

The origins of depression are multifactorial, involving a complex interplay of biological, psychological, and environmental factors. While researchers continue to explore the intricacies of these causes, several key contributors have been identified:

1. Biological Factors:

 Genetic predisposition plays a significant role in the development of depression. Individuals with a family history of the disorder may be more susceptible. Additionally, imbalances in neurotransmitters, such as serotonin and dopamine, are often observed in individuals with depression.[11]

2. Psychological Factors:

Trauma, loss, or chronic stress can trigger and exacerbate depressive episodes. Negative thought patterns, low self-esteem, and a history of childhood adversity contribute to the psychological aspects of depression[12-13]

3. Environmental Factors:

Living in a socioeconomically disadvantaged environment, experiencing social isolation, or facing ongoing life stressors can contribute to the onset and persistence of depression. Substance abuse and certain medications can also be environmental triggers.[14-15]

Recognizing the Symptoms:

Depression manifests in a myriad of symptoms, and its presentation can vary widely among individuals. Some common signs include:

Persistent Sadness:

An enduring feeling of sadness or emptiness that persists for most of the day

Loss of Interest or Pleasure:

A diminished interest in activities that once brought joy or satisfaction

Changes in Sleep Patterns: Insomnia or oversleeping can be indicative of depression.

Weight Changes:

Significant changes in appetite and weight, either an increase or decrease.

Fatigue and Low Energy:

A pervasive feeling of exhaustion, even after minimal physical or mental exertion.

Difficulty Concentrating:

Impaired cognitive function and an inability to focus on tasks.

Feelings of Worthlessness or Guilt:

A distorted sense of self-worth and excessive guilt, often unrelated to actual events.

Suicidal Thoughts:

In severe cases, individuals may contemplate or express thoughts of self-harm or suicide.[16-17]

Seeking Help

Recognizing the symptoms of depression is crucial, but taking the next step to seek help is equally important. Mental health professionals, including psychiatrists, psychologists, and therapists, play a vital role in diagnosis and treatment. Various therapeutic approaches, such as cognitive-behavioral therapy (CBT), medication, and lifestyle modifications, can be effective in managing and alleviating depressive symptoms.[18]

Breaking the Stigma

Despite the prevalence of depression, societal stigmas persist, hindering open conversations and discouraging individuals from seeking help. It is essential to foster an environment of understanding and compassion, dispelling myths and misconceptions surrounding mental health. Education, awareness campaigns, and open dialogue can contribute to breaking down these barriers and promoting empathy.

Supporting Loved Ones

If someone you know is struggling with depression, providing support and understanding is crucial. Active listening, offering assistance with practical tasks, and encouraging professional help are ways to be there for someone facing this challenging journey. However, it's essential to remember that you are not a substitute for professional intervention, and encouraging your loved one to seek help from a mental health professional is paramount.

Nurturing Mental Health

Preventive measures and self-care strategies are essential components of maintaining mental well-being. Incorporating regular exercise, adopting a balanced diet, prioritizing adequate sleep, and engaging in stress-reducing activities can contribute to overall mental health. Building an obust support network and cultivating resilience are vital elements in navigating life's challenges.

Depression is a complex and pervasive mental health condition that affects millions of people globally. Understanding its various forms, causes, symptoms, and available treatments is crucial for fostering empathy, reducing stigma, and promoting a supportive environment for those grappling with depression. By shedding light on the multifaceted nature of this silent struggle, we can collectively work towards creating a society that prioritizes mental health and well-being.[19]

POST-PARTUM

While the birth of a child is an exciting time, it also signals the start of a journey that will change the mother in ways that go well beyond the delivery room. Postpartum, sometimes called the "fourth trimester," is an important time that needs to be supported, understood, and given attention. This article explores the physical, emotional, and social components of the complicated experience of postpartum depression, delving into its many facets.[20]

The Physical Rollercoaster:

There is no denying that childbirth has a physical cost, and the postpartum phase is a period of recuperation and adjustment. A variety of physical symptoms, such as vaginal pain, uterine contractions, and bleeding, can affect mothers. Changes in hunger, weariness, and mood swings can all be caused by hormonal imbalances. Breastfeeding has a unique set of difficulties, ranging from engorgement to cracked nipples, despite being a popular choice for infant nutrition.

It is imperative that new mothers make self-care a priority during this time. A healthy diet, moderate exercise, and enough sleep can all help the body recuperate. Getting advice from medical experts and going to postpartum checkups guarantees that any issues or problems are taken care of right away.[21-22]

Emotional Waves:

The postpartum mental terrain is as diverse as the people who experience it. Some women may experience intense sentiments of happiness and attachment to their child, while others may struggle with melancholy, anxiety, or even depression. Regardless of age, origin, or financial situation, postpartum mood disorders, such as postpartum depression (PPD) and postpartum anxiety, are not uncommon and can affect any new mother.  It is essential to comprehend and de-stigmatize these mental health issues in order to create a helpful atmosphere. Friends, family, and partners are essential in offering emotional support and identifying when professional help might be required. Prioritizing mental health and providing easy access to counselling or therapy for people in need are important.[23]

Navigating Changes in Relationships:

New family members invariably change the dynamics of already-existing relationships. Couples may struggle with increased responsibilities, restless nights, and changes in their level of intimacy. During this time, couples should communicate openly and honestly to each other in order to overcome any obstacles that may come up. Friends and extended relatives can also be a part of a network of support. Assisting with domestic tasks, extending emotional help, and comprehending the distinct dynamics of the postpartum phase can fortify bonds and facilitate the shift into motherhood.[24-25]

The Importance of Community:

Building a community of support is crucial for new mothers. Sharing experiences, exchanging advice, and connecting with other parents can alleviate feelings of isolation. Online forums, local support groups, and parenting classes offer valuable opportunities for bonding and learning from others who are going through similar experiences.[26-27]

Creating a Supportive Environment:

The postpartum experience is shaped by society at large. A more supportive atmosphere can be created by encouraging companies to adopt family-friendly practices, normalizing the conversation around postpartum mental health, and making sure all moms have access to healthcare. Physical changes, emotional highs and lows, and changes in relationships are all hallmarks of the postpartum experience. Acknowledging the difficulties and proactively striving to establish a nurturing atmosphere are crucial for the welfare of recently arrived mothers. Every mother and her family can have a happy postpartum experience if society prioritizes mental and physical health, fosters understanding, and shows compassion. By accepting the intricacies of the postpartum period, we create the conditions for a more joyful and healthful shift into motherhood.[28-29]

POST-PARTUM DEPRESSION

A child's birth is typically regarded as an extremely happy occasion when families rejoice over the addition of a new member. However, postpartum depression (PPD), a disorder that casts a lengthy and heavy shadow, overshadows this time for some moms. In-depth discussions of postpartum depression's causes, symptoms, effects on moms and families, and coping and recovery techniques are provided in this article.

One kind of mood problem that strikes moms after giving birth is called postpartum depression. It is more than just the normal "baby blues," which include slight mood fluctuations, crying, and exhaustion that usually go away in a few weeks. The hallmarks of PPD are severe and ongoing depression symptoms that seriously impair a mother's capacity to go about her everyday activities.[30]

Causes and Risk Factors:

For postpartum depression to be identified and treated early, it is essential to comprehend its origins and risk factors. Its growth is influenced by a variety of biological, hormonal, and environmental factors, yet there isn't just one specific reason.  Hormonal changes are thought to contribute to PPD, especially a sharp decline in progesterone and estrogens levels following childbirth. Lack of sleep, which is typical for new moms, can make emotional distress worse. PPD is more likely to develop in people who have biological predispositions, such as a history of depression or other mental health conditions. There are additional social and environmental elements that raise the possibility of postpartum depression. PPD can arise from a number of factors, including interpersonal problems, financial stress, a history of trauma or abuse, and a weak support network.[31-32]

Recognizing Symptoms:

There are many different ways that postpartum depression presents itself, and it can cause both physical and emotional problems. Common symptoms include a loss of interest or pleasure in activities, irregular sleep patterns, a persistent sense of melancholy, hopelessness, or emptiness, and trouble bonding with the infant. Weariness, difficulty concentrating, and changes in appetite are examples of physical symptoms.  It's crucial to remember that PPD symptoms can differ in severity and length, and that every person will experience them in a unique way. Early detection of the symptoms is essential for obtaining help and care in a timely manner.[33]

Impact on Mothers and Families:

Postpartum depression affects the whole family in addition to the afflicted individual. It may be difficult for moms with PPD to carry out everyday duties and meet their caring obligations. Relationship problems with spouses and other family members may result from this, which may cause feelings of inferiority and guilt.  There may be repercussions for the emotional and cognitive development of children whose moms have PPD. A supportive atmosphere and early intervention are crucial to reducing the long-term effects on moms and their families.[34]

Seeking Help and Treatment:

Recognizing your need for support and asking for it is the first step towards beating postpartum depression. An essential part of diagnosing and treating PPD is the involvement of healthcare professionals. The mother's mental health should be discussed during routine postpartum check-ups so that medical personnel can look for and treat any signs of depression. There are many different ways to treat postpartum depression, such as counselling, medication, or a mix of the two. Cognitive-behavioral therapy (CBT) is frequently advised because it offers a methodical way to recognize and address harmful thought patterns. When administered and managed carefully, antidepressant drugs can also be useful in treating symptoms. In addition to formal treatment, building a strong support network is crucial for mothers with PPD. Partners, family members, and friends can provide emotional support, assist with daily tasks, and create a nurturing environment for the mother and baby.[35]

DIAGNOSIS OF POST PARTUM DEPRESSION

An important first step in the early diagnosis and treatment of postpartum mood disorders is screening. To assist healthcare practitioners in identifying women who may be at risk or exhibiting symptoms of postpartum mood disorders, a variety of screening instruments and questionnaires have been created. With the use of these techniques, symptoms can be systematically assessed, facilitating prompt support and intervention. These are three frequently used screening instruments.

The Edinburgh Postnatal Depression Scale (EPDS)

This is a popular self-report tool used to evaluate postpartum women's depression symptoms, including their severity. It has ten items total, covering a spectrum of feelings and actions connected to depression. The EPDS is able to given as early as the first several weeks following childbirth and has a long history of successful validation in the identification of postpartum depression. The EPDS cut-off value of 11 or above indicated the ideal ratio of sensitivity to specificity, maximizing their combined efficacy. A cut-off value of 13 or above, on the other hand, indicated greater specificity but decreased sensitivity. A cut-off of 13 or higher would be suitable for identifying postpartum and pregnant women with heightened symptom levels. On the other hand, if the objective is to reduce the incidence of false negatives and include more individuals who satisfy the diagnostic requirements.[36]

The Postpartum Depression Screening Scale (PDSS)

This is a thorough self-report tool designed to evaluate postpartum depression symptoms. This scale includes a wider range of typical postpartum emotional and physical symptoms. It fully determines the type and intensity of depression symptoms, allowing medical professionals to identify women who might need additional testing or treatment.[37]

Generalized Anxiety Disorder 7 (GAD-7)

The GAD-7 is widely used as a screening tool for anxiety symptoms, which frequently co-occur with postpartum depression, despite not being explicitly created for postpartum mood disorders. Seven items make up the GAD-7, which rates the degree of generalized anxiety. signs. It gives medical professionals important information about the frequency and intensity of anxiety symptoms, which helps them identify women who might need more evaluation or assistance. These screening measures, together with others, have an 89% sensitivity and an 82% specificity, making them useful tools for healthcare professionals in detecting and tracking postpartum mental disorders. Using approved technologies for routine screening, medical professionals can quickly discover women who are exhibiting symptoms or at risk, enabling prompt intervention and suitable therapy. It is crucial to remember that in order to guarantee an accurate diagnosis and customize the treatment plan to meet the needs of each woman, a thorough clinical examination should be conducted in addition to screening.[38]

CHALLENGES AND LIMITATIONS IN DIAGNOSING POSTPARTUM MOOD DISORDERS

Intermittent symptoms: The co-occurrence of symptoms with typical postpartum adaptation poses a difficulty in the diagnosis of postpartum mood disorders. After giving delivery, there may be physical and emotional changes that resemble the signs of postpartum mood disorders, including weariness, depression, and alterations in appetite. Because of these similarities, it may be challenging for medical professionals to distinguish between a mood illness and a typical adjustment, which could result in an underdiagnosis or misinterpretation [39] Variability of presentation: Individual differences in the manifestation of postpartum mood disorders might be significant. These diseases can take many different forms. The intensity, duration, and precise expression of symptoms can vary. For instance, whilst some women may mostly have depressed symptoms, others may exhibit symptoms that are primarily anxiety-related or even psychotic. This variety complicates diagnosis since medical professionals have to carefully consider each patient's particular symptomatology in order to arrive at a diagnosis. Lack of knowledge and stigma: Both the general public and medical professionals generally lack knowledge and comprehension of postpartum mood disorders. This ignorance may cause symptoms to go unnoticed and prevent prompt assistance from being sought. Furthermore, the stigma attached to Women may face obstacles when it comes to seeking mental health support or being candid about their feelings. Women may be reluctant to disclose their symptoms for fear of being stigmatized by society or seen as unfit mothers, which would further impede the diagnostic procedure. Healthcare professionals play a critical role in fostering an accepting and judgment-free atmosphere that promotes candid conversation and gives women the confidence to ask for assistance.[40] Improving public and healthcare practitioner knowledge and understanding of postpartum mood disorders is necessary to address these issues. Increased education for medical staff can assist them in identifying subtle differences in symptom presentation and distinguishing between normal adjustment and emotional problems. Furthermore, initiatives to lessen the stigma attached to mental health should be undertaken in order to provide a secure environment where women can talk about their experiences without worrying about being judged. Through tackling these obstacles, medical professionals can enhance the precision of diagnoses and guarantee that women obtain suitable assistance and therapy for mental disorders following childbirth.[41]

Importance of Early Detection and Intervention

Detecting and treating postpartum mental disorders at an early stage is essential. Early detection of symptoms reduces the likelihood of adverse effects on the mother, child, and family by enabling timely intervention. Additionally, prompt action may be able to stop the escalation  of symptoms and the emergence of chronic or more serious illnesses. Enhancing assistance and education is a major advantage of early detection. Healthcare practitioners can give appropriate support, information, and resources to women who exhibit signs of postpartum mood disorders or who are at risk for them by recognising these women. This makes it easier for women and their families to comprehend the illness more effectively and create useful coping mechanisms. Healthcare providers can enhance the general well-being of afflicted persons and their families by offering prompt information and assistance. Creating individualised treatment programmes is another benefit of early detection. Armed with early symptom knowledge, medical professionals can develop customised treatment plans that cater to the unique requirements of every woman. These treatment regimens could combine psychological among other methods, include social support, medication, and interventions. Healthcare providers can increase the chance of successful outcomes and speed up the healing process by starting therapy early.[42-44]

COPING STRATEGIES FOR POSTPARTUM DEPRESSION:

Mothers experiencing postpartum depression can integrate many coping tactics into their daily life, apart from seeking professional treatment. These strategies include:

Self-Care:

Make self-care routines a priority, including getting enough sleep, eating a balanced diet, and doing relaxing and joyful things.

Reach Out for Support:

Talk about your emotions and experiences with family, close friends, or a support group. Making connections with those who have had like hardships can be incredibly consoling.

Set Realistic Expectations

Recognize that the postpartum phase is a moment of transition and that it's acceptable to not have all the answers. It's crucial to set reasonable goals for oneself and ask for help when required.

Establish Routine:

Establishing a regular daily schedule helps give both the mother and the child a sense of security and consistency.

Physical Activity:

Including mild exercise in your regular routine can improve your mood and general wellbeing. An even little stroll outside can have a big impact.[45]

TREATMENT FOR POST PARTUM DEPRESSION:

Psychotherapy

Initially, psychotherapy was utilized to treat mild to moderate cases of postpartum unipolar major depression. This method is very helpful for nursing patients who do not want to give their infants antidepressant exposure, and it is in line with several practice standards. Individual psychotherapy sessions are the norm for psychotherapy; among the general population of patients with major depression and postpartum depression, cognitive-behavioral therapy or interpersonal psychotherapy are most frequently utilized due to their proven effectiveness in several randomized trials. Developing communication skills is one of the many beneficial aspects of group therapy. Other benefits include normalizing one's problems by getting support (such as guidance, empathy, and validation) from other patients going through similar experiences, decreasing social isolation and loneliness, boosting one's sense of belonging and companionship, and learning from the modelling of others.[46]

Cognitive- Behavioral Therapy (CBT):

CBT is a widely recognized and evidence-based psychotherapy approach to treating postpartum mood disorders. CBT focuses on identifying and challenging negative thought patterns and behaviors contributingto emotional distress. Through this therapy, individuals learn to recognize and modify unhelpful thoughts, beliefs, and attitudes, which can alleviate symptoms of postpartum depression ,anxiety, and other mood disorders. CBT equips individuals with coping strategies, problem-solving skills, and relaxation techniques to manage stress, improve mood, and enhance overall emotional well-being. The collaborative nature of CBT allows individuals to actively participate in their treatment actively, fostering a sense of empowerment and control over their emotions.[47]

Interpersonal Psychotherapy (IPT) :

IPT is another well-established psychotherapy approach for treating postpartum mood disorders. IPT addresses interpersonal problems and conflicts that may contribute to developing or exacerbating symptoms. It recognizes the impact of social relationships on an individual's mental health and aims to improve communication, interpersonal relationships, and social support networks. IPT typically involves exploring the individual's relationships and identifying difficulties, such as role transitions, unresolved grief, interpersonal disputes, or social isolation. By addressing these interpersonal issues, IPT helps individuals build healthier methods of relating to others, boosting their general well-being and reducing symptoms of postpartum mood disorders.[48]

Alternative and Complementary Therapies

Mindfulness-based interventions:

Postpartum mood disorders can be effectively treated with mindfulness-based therapies, such as mindfulness-based cognitive therapy (MBCT) or mindfulness-based stress reduction (MBSR). These therapies focus on developing self-compassion, nonjudgmental acceptance, and present-moment mindfulness. Research has indicated that engaging in Postpartum mindfulness can improve overall mental health by lowering stress and fostering emotional well-being. Relapse prevention has also been shown to be a benefit of mindfulness-based therapies for those with a history of anxiety or postpartum depression. People can increase their resilience and learn flexible coping mechanisms to deal with the difficulties brought on by postpartum mood disorders by practicing mindfulness.[49]

Yoga and exercise

Yoga and other forms of regular physical activity are also promising treatments for postpartum mood issues. Numerous mental health advantages of physical activity include elevated mood, decreased anxiety, and increased general wellbeing. Specifically, yoga incorporates physical movement, Using mindfulness, breath control, and other holistic techniques, one can enhance both physical and mental well-being. Postpartum yoga practice has been shown to have a positive impact on anxiety reduction, depression symptoms, and sleep quality. Yoga's gentle poses and focus on body awareness and relaxation can help reduce stress and foster a sense of balance and tranquilly. Additionally, taking part in physical activities with other postpartum people or taking part in group fitness courses can offer social support and a sense of community, both of which are good for psychological well-being.[50]

Multidisciplinary Approaches for Comprehensive Care

Collaborative care models

Models of collaborative care are critical to the treatment of postpartum mood disorders.  In order to offer women in need with comprehensive treatment, these models place a strong emphasis on the coordination and integration of medical professionals, mental health specialists, and support services. Together, these Experts make sure that therapy, medication administration, and social support are all taken care of during treatment. The collaborative care approach acknowledges that treating postpartum mood disorders requires a multifaceted strategy. By combining their knowledge, the care team may create customised treatment programmes that are suited to the unique requirements of each woman. Additionally, by encouraging collaboration and communication across various healthcare practitioners, this paradigm improves the efficacy and continuity of care. Women with postpartum mental disorders can receive comprehensive and coordinated support by using a collaborative care paradigm, which will improve long-term.[51]

Postpartum support programs

Programmes for postpartum support are essential for offering women with postpartum mood disorders all encompassing care. These initiatives provide a variety of services with the goal of meeting the unique needs of women at this trying time. Services for counselling offer a  a secure and encouraging setting where women may talk about their worries, express their feelings, and get expert advice. Support groups provide a sense of community and validation by uniting people with similar experiences. Educational resources provide important knowledge on self-care practices, coping mechanisms, and postpartum mood disorders. By ensuring that women receive individualised care coordination, case management enables them to access the right resources and successfully navigate the healthcare system. Programmes for postpartum support acknowledge the significance of treating postpartum mood disorders on an emotional, psychological, and practical level.[52]

Pharmacotherapy:

Antidepressants (e.g., Selective Serotonin Reuptake Inhibitors [SSRIs], serotonin-norepinephrine reuptake inhibitors, bupropion, and mirtazapine) are a reasonable alternative if psychotherapy is not available, not successful, or is declined, or if the patient has previously responded to antidepressants. In addition, combination treatment with pharmacotherapy plus psychotherapy is helpful for some patients. Pharmacologic recommendations for lactating women should include discussing the benefits of breastfeeding, the risks of antidepressant use during lactation, and the risks of untreated illness. For patients with mild to moderate unipolar major depression who are breastfeeding and choose treatment with an antidepressant, there is a consensus that the benefits of medications outweigh the potential dangers to the newborn. The hazards are viewed as modest; for example, most SSRIs pass into breast milk at a dose less than 10 per cent of the maternal level and are generally deemed compatible with breastfeeding of healthy, full-term infants Acute treatment for nursing patients with severe major depression following childbirth is based on the patient's choices and clinical history. Antidepressants such selective serotonin reuptake inhibitors (SSRIs) and the more recently produced antidepressant brexanolone are the main therapy. electroshock treatment (ECT). [53]

Selective Serotonin Reuptake Inhibitors (SSRIs)

This group is more widely investigated in nursing patients than other antidepressant classes; because of their efficacy and tolerability for postpartum depression. For example, a retrospective analysis of women (n = 459) treated for postpartum depression with antidepressants indicated that SSRIs were used in 90 percent. For those suffering from severe serious depression, we recommend starting SSRI medication for postpartum depression in women who are breastfeeding and have never taken antidepressants before due to its effectiveness and tolerability.

Compared to other antidepressant classes, SSRIs have been used and studied more extensively in patients who are breastfeeding; for instance, a retrospective analysis of 459 women treated with antidepressants for postpartum depression discovered that 90% of the women utilized SSRIs. Because of the class's seeming benign safety record, each single SSRI can be taken. However, serotonin-norepinephrine reuptake inhibitors (SNRIs), mirtazapine, and nortriptyline are all suitable substitutes for SSRIs.[54]

MITRAZAPINE

A potent antidepressant with a distinct mode of action is mirtazapine. It has numerous distinct therapeutic advantages, a favorable side-effect profile, a high response and remission rate, and a comparatively quick commencement of action. Additionally, mirtazapine has demonstrated promise in the treatment of a number of medical diseases, including neurologic abnormalities, as well as in the reduction of some of the crippling side effects associated with weight loss, sleeplessness, and postoperative nausea and vomiting.[55]

Brexanolone

Allopregnanolone is a synthetic formulation of the progesterone metabolite and a neuroactive steroid . The US Food and Drug Administration (FDA) approved the first antidepressant for the treatment of postpartum depression in 2019: intravenous brexanolone. Randomized trials, when a small percentage of patients also got antidepressants at the same time, show that a 60-hour brexanolone infusion can result in a quick and helpful recovery for moderate to severe postpartum major depression. In independent pooled analyses of the same three studies, 209 patients were compared between brexanolone and a placebo.[56]

SEROTONIN AND NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIs)

In the United States, serotonin-norepinephrine reuptake inhibitors, or SNRIs, are among the most often given drugs each year. The primary mechanism of action is, as the name implies, the suppression of 5-HT (serotonin) and norepinephrine presynaptic neuronal absorption after release from the synaptic cleft. The central nervous system's synaptic cleft retains these monoamines for a longer period of time when reuptake is prevented. Consequently, this leads to more post-synaptic neuronal transmission and enhanced postsynaptic receptor stimulation. The Food and Drug Administration (FDA) has authorised the use of five primary SNRIs in the US at this time. Because of their mechanism, SNRIs are frequently said to have a "dual action," yet the precise degree of norepinephrine and serotonin reuptake inhibition is dose-dependent.[57]

DUOLOXETINE

The second SNRI to receive FDA approval for usage in the US was duloxetine. Diabetic peripheral neuropathy was one of the original clinical indications for duloxetine, and it was the first medication approved in the US for this illness. Since its launch, the FDA has approved duloxetine for the treatment of osteoarthritis, fibromyalgia, severe depression, musculoskeletal pain, and generalised anxiety disorder.. Duloxetine, in contrast to venlafaxine, offers several therapeutic indications for nonpsychiatric illnesses, each of which corresponds to a distinct kind of pain syndrome. The chemical structure of duloxetine differs from that of venlafaxine in that it consists of three rings, two of which are next to one another. In late, duloxetine emerged as a potential generic formulation.[58]

Tricyclic Antidepressants (TCAs)

Major depressive disorder (MDD) is treated and managed with a class of drugs called tricyclic antidepressants (TCAs). These drugs work by preventing the reuptake of neurotransmitters that influence mood, attention, and pain perception in people, such as norepinephrine and serotonin. Different TCAs have been licenced by the US Food and Drug Administration for particular applications based on clinical trials and solid proof of their safety and efficacy for particular medical problems. TCAs are advised as a second-line treatment for MDD after selective serotonin reuptake inhibitors, according to evidence-based guidelines. TCAs and SSRIs show equivocal efficacy in treating MDD; however, because of their anticholinergic activity and lower threshold for overdose, TCAs have more severe side effects. TCAs are often not regarded as the first-line treatment for MDD because of these reasons despite the fact that they have shown to be incredibly successful in treating severe or treatment-resistant depression. In order to improve the competency of interprofessional healthcare team members when providing care for patients with MDD and related conditions, this activity highlights the mechanism of action, indications, contraindications, adverse event profile, monitoring protocols, pertinent interactions, off-label uses, and other crucial aspects of TCA therapy on a clinical level.[59]

Imipramine

Anxiety and depression are conditions that are treated with imipramine. It is a tricyclic antidepressant with tertiary amines. This exercise goes over the activity, adverse effects, activity, and other important aspects of imipramine therapy in the clinical setting, including ongoing medication monitoring and the immediate treatment of tricyclic overdose. When caring for patients on imipramine therapy, interprofessional team members will find these variables to be crucial and therapeutically relevant.Anxiety and depression are conditions that are treated with imipramine. It is a tricyclic antidepressant with tertiary amines. This exercise goes over the activity, adverse effects, activity, and other important aspects of imipramine therapy in the clinical setting, including ongoing medication monitoring and the immediate treatment of tricyclic overdose. When caring for patients on imipramine therapy, interprofessional team members will find these variables to be crucial and therapeutically relevant.[60]

Electroconvulsive therapy (ECT)

It is beneficial when rapidly effective treatment is imperative; specific indications include psychotic depression, plans and intent to commit suicide or infanticide, and fluid and food refusal leading to dehydration and malnutrition [61]

Treatment-resistant patients

Patients with severe postpartum major depression often do not respond to initial treatment with an antidepressant . If there is little improvement (less than twenty-five percent), it is advised to move from augmentation to another antidepressant. Alternatives include moving to an SNRI, an SSRI, or the Mirtazapine, often known as the tricyclic nortriptyline, is an atypical antidepressant [50].Certain medications (such bupropion and doxepin) are generally avoided by patients transitioning to another antidepressant because of worries about their safety when nursing infants. Rather than switching antidepressants, we administer a second medication that is safe for nursing to lactating women who show a partial response to initial treatment (e.g., reduction of baseline symptoms by 25 to 49 percent). If an antidepressant is stopped before delivery, it may be able to treat antenatal major depression. Resuming the antidepressant is therefore recommended for patients who go on to develop postpartum major depression while breastfeeding, even if there are better lactation safety data for other medications. This is because switching to a different antidepressant increases the number of drug exposures, and the amount of antidepressant exposure that occurs in utero is significantly higher than that through breast milk. Patients who exhibit severe postpartum major depression and have previously experienced a depressive episode that was effectively treated with medication will benefit from continuing on the same regimen, as long as it is lactation-compatible. This includes antidepressant-based medication regimens combined with add-on treatment with lithium, triiodothyronine, or another second-generation antipsychotic.[62]

Psychotic depression

Nursing patients with psychotic severe depression respond similarly to non-postpartum patients. Antidepressants and antipsychotics are used to treat psychotic depression; however, because ECT acts very quickly, it makes sense to use it as a first line of treatment.[63]

Anxiety or insomnia

Monotherapy with antidepressant medication is preferred over combination antidepressant and benzodiazepine for breastfeeding patients with major postpartum depression that includes significant anxiety or insomnia. Specifically, randomized trials comparing brexanolone with placebo have demonstrated efficacy for anxiety and insomnia. However, for patients with severe anxiety or insomnia, we often prescribe both an antidepressant and a benzodiazepine at the onset of treatment. Adjunctive benzodiazepines can also help with intractable anxiety or insomnia. Caution in benzodiazepines is warranted in patients with a history of substance-related and addictive disorders.[64]

Agitation

Agitation episodes, which are characterized as unproductive, excessive motor activity combined with interior stress, are a possible feature of severe major depression. When assessing agitation in patients with a confirmed severe depressive diagnosis, the first goal should be to rule out other possible explanations of the agitation, such as a general illness, or drunkenness or drug withdrawal from drugs like cocaine, alcohol, or methamphetamines.  In addition to seclusion from other patients and physical restrictions, oral, inhaled, or injectable medicines are frequently needed to treat threatening or aggressive conduct in hospitalized postnatal patients with severe major depression who are extremely agitated.[65]

Breaking the Stigma

The stigma associated with mental illness is one of the major obstacles to treating postpartum depression. It's critical to promote honest and nonjudgmental dialogues around PPD, enabling those who are impacted to ask for assistance without worrying about being misunderstood or criticized. Dispelling these myths requires educating the public about postpartum depression, how common it is, and how crucial assistance is. We can encourage moms to seek treatment, lessen feelings of loneliness, and ultimately enhance outcomes for mothers and their families by fostering a culture that prioritizes mental health.[66]

FUTURE SCOPE

Future research on postpartum depression (PPD) could lead to significant improvements in knowledge, prevention, and care. Future PPD research and intervention will be concentrated on a number of important areas as our understanding of mental health continues to advance.

Precision Medicine and Personalized Treatments:

Developments in neuroscience and genetics could lead to the creation of individualised postpartum depression therapy. Customising therapies according to a person's hormone levels, genetic composition, and unique neurological characteristics may result in more focused and successful treatment modalities.

Early Detection and Prevention:

Finding early indicators or risk factors for postpartum depression is probably going to be the main focus of future research. The creation of trustworthy biomarkers or predictive models may make it possible for medical professionals to act early and stop the emergence of serious symptoms.

Technology-Based Interventions:

The incorporation of technology, such as wearables, telehealth platforms, and mobile applications, presents creative approaches to tracking and assisting those suffering from postpartum depression. Virtual therapy sessions and real-time support through mobile applications are examples of digital therapies that could play a significant role in PPD management.

Cultural Sensitivity and Diversity:

Anticipated investigations will probably prioritise comprehending the ways in which cultural elements impact the manifestation, communication, and interpretation of postpartum depression. In order to effectively support all mothers, interventions must be crafted with cultural sensitivity and recognition of differing viewpoints.

Preconception Mental Health Care:

One of the main goals could be to acknowledge the significance of mental health before conception. Preconception mental health care might include treating mental health issues that already existed, supporting those who have experienced depression in the past, and fostering general emotional health before becoming pregnant.

Partner and Family Involvement:

Subsequent interventions might prioritise the inclusion of partners and extended family members in the support system for recently arrived mothers. Including spouses in therapy sessions and educational programmes can help promote a more family-centered and holistic approach to postpartum depression.

Community-Based Support Programs:

It is anticipated that community-based initiatives providing instructional materials, accessible mental health treatments, and support groups will become more well-known. Building a network of neighbourhood resources helps lessen the stigma attached to postpartum depression and give moms a place to feel supported.

Workplace Mental Health Initiatives:

It's possible that employers are becoming more aware of how postpartum depression affects workers. Future projects might concentrate on putting in place workplace regulations that assist new moms' mental health, such as access to mental health resources, paid family leave, and flexible scheduling.

Long-Term Impact on Child Development:

It seems likely that study on the long-term effects of postpartum depression on child development will continue. Comprehending the impact of maternal mental health on a child's cognitive, emotional, and social growth can help shape early intervention tactics and family support initiatives.

Global Mental Health Advocacy:

Research and treatment for postpartum depression will continue to be conducted internationally in the future. Global attention to mental health advocacy, knowledge, and easily available services can help to advance a more thorough and equitable strategy for dealing with postpartum depression globally.

A multimodal strategy that incorporates advances in science, technology, cultural sensitivity, and community-based support characterises the future scope of postpartum depression. The ultimate goal is to improve maternal mental health and well-being by fostering a more proactive, inclusive, and supportive environment for new moms as our understanding of postpartum depression grows. [67-68]

CONCLUSION:

Effective care of postpartum depression necessitates a comprehensive strategy, given its complex and diverse nature. We can equip moms to face the shadows of PPD and come out stronger on the other side by knowing the reasons, identifying the symptoms, and creating a supportive atmosphere. Making the stigma associated with mental health disappear, providing expert assistance, and intervening early are all crucial to maintaining mothers' wellbeing during this delicate time. By fostering empathy, knowledge, and candid communication, we can all work together to create a community that is more sympathetic and accepting to individuals dealing with postpartum depression. Postpartum depression is a complicated issue with many facets that calls for an all-encompassing and considerate strategy. It is clear that we need to work together to support new moms on their path to mental well-being as we work to comprehend, diagnose, and treat   the multiple aspects of this disorder Postpartum depression has become much more widely known, shattering taboo and encouraging candid discussions about the mental health of mothers. To guarantee that every woman gets the attention and assistance she requires at this delicate time, there is still more work to be done.Research, innovation, and a dedication to individualised, culturally aware, and community-centered therapies are key to the future of postpartum depression. By accepting the fact that mental health is a dynamic field, we can provide spaces where moms feel free to ask for assistance without fear of stigma and where medical professionals can respond quickly and efficiently. Understanding the connections between physical, mental, and social aspects is essential as we work through the complexity of postpartum depression. There is hope for better results for moms and their children in the future, from technology-driven interventions and personalised treatments to early detection and worldwide campaigning. In the end, treating postpartum depression necessitates a comprehensive strategy that includes social, professional, and community support networks in addition to clinical settings. By placing a high priority on maternal mental health, we can improve the wellbeing of individual moms as well as foster healthier families and communities. Let's keep dismantling obstacles, confronting stigmas, and promoting an understanding- and empathy-centered culture in this changing environment. By doing this, we open the door to a time when all mothers will be able to enjoy the benefits of motherhood while overcoming the obstacles caused by postpartum depression with the help and fortitude that they require.

REFERENCES

1. Deng, Z. D.; Robins, P. L.; Regenold, W.; Rohde, P.; Dannhauer, M.; Lisanby, S. H. How Electroconvulsive Therapy Works in the Treatment of Depression: Is It the Seizure, the Electricity, or Both? Neuropsychopharmacology 2024, 49 (1), 150–162.
2. Shetty, A. P.; Halemani, K.; Issac, A.; Thimmappa, L.; Dhiraaj, S.; Radha, K.; Mishra, P.; Upadhyaya, V. D. Prevalence of Anxiety, Depression, and Stress among Parents of Neonates Admitted to Neonatal Intensive Care Unit: A Systematic Review and Meta-Analysis. Clin. Exp. Pediatr. 2024, 67 (2), 104.
3. Bulteau, S.; Malo, R.; Holland, Z.; Laurin, A.; Sauvaget, A. The Update of Self?Identity: Importance of Assessing Autobiographical Memory in Major Depressive Disorder. Wiley Interdiscip. Rev.: Cogn. Sci. 2023, e1644, 1–12.
4. Belov, V.; Erwin-Grabner, T.; Aghajani, M.; Aleman, A.; Amod, A. R.; Basgoze, Z.; Benedetti, F.; Besteher, B.; Bülow, R.; Ching, C. R.; Connolly, C. G. Multi-Site Benchmark Classification of Major Depressive Disorder Using Machine Learning on Cortical and Subcortical Measures. Sci. Rep. 2024, 14 (1), 1084.
5. Walter HJ, Abright AR, Bukstein OG, Diamond J, Keable H, Ripperger-Suhler J, Rockhill C. Clinical practice guideline for the assessment and treatment of children and adolescents with major and persistent depressive disorders. Journal of the American Academy of Child & Adolescent Psychiatry. 2023 May 1;62(5):479-502.
6. Schramm, E.; Klein, D. N.; Elsaesser, M.; Furukawa, T. A.; Domschke, K. Review of Dysthymia and Persistent Depressive Disorder: History, Correlates, and Clinical Implications. Lancet Psychiatry 2020, 7 (9), 801–812.
7. Nevarez-Flores, A. G.; Bostock, E. C.; Neil, A. L. The Underexplored Presence of Seasonal Affective Disorder in the Southern Hemisphere: A Narrative Review of the Australian Literature. J. Psychiatr. Res. 2023, DOI: 10.1016/j.jpsychires.2023.05.003.
8. Wescott, D. L.; Franzen, P. L.; Hasler, B. P.; Miller, M. A.; Soehner, A. M.; Smagula, S. F.; Wallace, M. L.; Hall, M. H.; Roecklein, K. A. Elusive Hypersomnolence in Seasonal Affective Disorder: Actigraphic and Self-Reported Sleep In and Out of Depressive Episodes. Psychol. Med. 2023, 53 (4), 1313–1322.
9. Parker, G.; Spoelma, M. J. A Chat about Bipolar Disorder. Bipolar Disord. 2023, DOI: 10.1111/bdi.13210.
10. Latifian, M.; Abdi, K.; Raheb, G.; Islam, S. M.; Alikhani, R. Stigma in People Living with Bipolar Disorder and Their Families: A Systematic Review. Int. J. Bipolar Disord. 2023, 11 (1), 1–20.
11. Khalsa, S. R.; McCarthy, K. S.; Sharpless, B. A.; Barrett, M. S.; Barber, J. P. Beliefs about the Causes of Depression and Treatment Preferences. J. Clin. Psychol. 2011, 67 (6), 539–549.
12. Botha, F. B.; Dozois, D. J. The Influence of Emphasizing Psychological Causes of Depression on Public Stigma. Can. J. Behav. Sci./Rev. Can. Sci. Comport. 2015, 47 (4), 313.
13. Biaggi, A.; Conroy, S.; Pawlby, S.; Pariante, C. M. Identifying the Women at Risk of Antenatal Anxiety and Depression: A Systematic Review. J. Affect. Disord. 2016, 191, 62–77. DOI: 10.1016/j.jad.2015.11.014.
14. Hu, Y.; Yiu, V.; Clark, R. Etiology of Depression: Biological and Environmental Factors in the Development of Depression. J. Student Res. 2021, 10 (4).
15. Nabeshima, T.; Kim, H. C. Involvement of Genetic and Environmental Factors in the Onset of Depression. Exp. Neurobiol. 2013, 22 (4), 235.
16. Benasi, G.; Fava, G. A.; Guidi, J. Prodromal Symptoms in Depression: A Systematic Review. Psychother. Psychosom. 2021, 90 (6), 365–372.
17. Pede, V. B.; Jaiswal, S. V.; Sawant, V. A. Study of Prodromal and Residual Symptoms of Depression. Ind. Psychiatry J. 2017, 26 (2), 121.
18. Manso-Córdoba, S.; Pickering, S.; Ortega, M. A.; Asúnsolo, Á.; Romero, D. Factors Related to Seeking Help for Postpartum Depression: A Secondary Analysis of New York City PRAMS Data. Int. J. Environ. Res. Public Health 2020, 17 (24), 9328.
19. Hudson, M. Climate Change and Energy Transition: Perceptions of Emergency, Responsibility, and the Future Imaginaries of Manitoban Unionized Workers. Futures 2024, Feb 8, 103339.
20. Grandi, G.; Del Savio, M. C.; Tassi, A.; Facchinetti, F. Postpartum Contraception: A Matter of Guidelines. Int. J. Gynecol. Obstet. 2024, 164 (1), 56-65.
21. Zedan, H. S.; Baattaiah, B. A.; Alashmali, S.; Almasaudi, A. S. Risk of Postpartum Depression: The Considerable Role of Maternal Health Status and Lifestyle. InHealthcare 2023, 11 (14), 2074. MDPI.
22. Scime, N. V.; Metcalfe, A.; Nettel-Aguirre, A.; Nerenberg, K.; Seow, C. H.; Tough, S. C.; Chaput, K. H. Breastfeeding Difficulties in the First 6 Weeks Postpartum Among Mothers with Chronic Conditions: A Latent Class Analysis. BMC Pregnancy Childbirth 2023, 23 (1), 90
23. Rodgers, R. F.; Campagna, J.; Hayes, G.; Sharma, A.; Runquist, E.; Fiuza, A.; Coburn-Sanderson, A.; Zimmerman, E.; Piran, N. Sociocultural Pressures and Body-Related Experiences During Pregnancy and the Postpartum Period: A Qualitative Study. Body Image 2024, Mar 1;48:101643.
24. Borràs-Novell, C.; Herranz Barbero, A.; Balcells Esponera, C.; López-Abad, M.; Aldecoa Bilbao, V.; Izquierdo Renau, M.; Iglesias Platas, I. Influence of Maternal and Perinatal Factors on Macronutrient Content of Very Preterm Human Milk during the First Weeks after Birth. J. Perinatol. 2023, 43 (1), 52-9.
25. Takagi, Y.; Hanahara, K.; Tateoka, Y. Actual Sleep Conditions from the Last Trimester of Pregnancy to Three Months Postpartum and the Associated Minor Problems. Adv. Obstet. Gynecol. Res. 2023, 1 (1), 13-23.
26. Heck, J. L.; Jones, E. J.; Parker, J. G. Establishment of a Community Advisory Board to Address Postpartum Depression Among Indigenous Women. J. Obstet. Gynecol. Neonatal Nurs. 2023, Jun 6.
27. Guo, P.; Wang, S.; Niu, M.; Yang, H.; Yun, Y.; Zhao, D.; Wu, C.; Wang, P.; Wang, S.; Wang, P.; Ma, R. Development of a Family-Community Interaction Programme in the Treatment of Women with Postpartum Depression: Protocol for a Randomized Controlled Trial. BMJ Open 2023, 13 (2), e059060
28. Matsumura, K.; Morozumi, R.; Hamazaki, K.; Tsuchida, A.; Inadera, H. Effect Estimate of Time-Varying Social Support and Trust on the Physical and Mental Health of Mothers at 2.5 Years Postpartum: The Japan Environment and Children’s Study (JECS). J. Epidemiol. 2023, 33 (4), 177-85.
29. Orchard, E. R.; Voigt, K.; Chopra, S.; Thapa, T.; Ward, P. G.; Egan, G. F.; Jamadar, S. D. The Maternal Brain Is More Flexible and Responsive at Rest: Effective Connectivity of the Parental Caregiving Network in Postpartum Mothers. Sci. Rep. 2023, 13 (1), 4719.
30. Saharoy, R.; Potdukhe, A.; Wanjari, M.; Taksande, A. B. Postpartum Depression and Maternal Care: Exploring the Complex Effects on Mothers and Infants. Cureus 2023, 15 (7).
31. Luo, F.; Zhu, Z.; Du, Y.; Chen, L.; Cheng, Y. Risk Factors for Postpartum Depression Based on Genetic and Epigenetic Interactions. Mol. Neurobiol. 2023, 60 (7), 3979-4003. DOI
32. El Saied, H. F.; Eissa, A.; El Kholy, T. S. A Cross-sectional Study of Risk Factors for Postpartum Depression. Egypt. J. Psychiatry 2021, 42 (2), 108. DOI
33. Gidén, K.; Vinnerljung, L.; Iliadis, S. I.; Fransson, E.; Skalkidou, A. Feeling Better? – Identification, Interventions, and Remission among Women with Early Postpartum Depressive Symptoms in Sweden: A Nested Cohort Study. Eur. Psychiatry 2024, 67 (1), e14. DOI: 10.1192/j.eurpsy.2024.6
34. Cafiero, P. J.; Zabala, P. J. Postpartum Depression: Impact on Pregnant Women and the Postnatal Physical, Emotional, and Cognitive Development of Their Children. An Ecological Perspective. Arch. Argent. Pediatr. 2024, ASAP. DOI
35. Manso-Córdoba, S.; Pickering, S.; Ortega, M. A.; Asúnsolo, Á.; Romero, D. Factors Related to Seeking Help for Postpartum Depression: A Secondary Analysis of New York City PRAMS Data. Int. J. Environ. Res. Public Health 2020, 17, 9328. DOI: 10.3390/ijerph17249328
36. Levis, B.; Negeri, Z.; Sun, Y.; Benedetti, A.; Thombs, B. D. Accuracy of the Edinburgh Postnatal Depression Scale (EPDS) for Screening to Detect Major Depression Among Pregnant and Postpartum Women: Systematic Review and Meta-Analysis of Individual Participant Data. BMJ 2020, 371, m4022. DOI: 10.1136/bmj.m4022
37. Vogeli, J. M.; Hooker, S. A.; Everhart, K. D.; Kaplan, P. S. Psychometric Properties of the Postpartum Depression Screening Scale Beyond the Postpartum Period. Res. Nurs. Health 2018, 41, 185–194. DOI: 10.1002/nur.21875
38. Simpson, W.; Glazer, M.; Michalski, N.; Steiner, M.; Frey, B. N. Comparative Efficacy of the Generalized Anxiety Disorder 7-Item Scale and the Edinburgh Postnatal Depression Scale as Screening Tools for Generalized Anxiety Disorder in Pregnancy and the Postpartum Period. Can. J. Psychiatry 2014, 59 (8), 434-440. DOI: 10.1177/070674371405900806
39. Batt MM, Duffy KA, Novick AM, Metcalf CA, Epperson CN. Is postpartum depression different from depression occurring outside of the perinatal period? A review of the evidence. Focus. 2020 Apr;18(2):106-19.
40. Stewart, D. E.; Vigod, S. N. Postpartum Depression: Pathophysiology, Treatment, and Emerging Therapeutics. Annu. Rev. Med. 2019, 70, 183-196. DOI: 10.1146/annurev-med-052117-021019
41. Manso-Córdoba, S.; Pickering, S.; Ortega, M. A.; Asúnsolo, Á.; Romero, D. Factors Related to Seeking Help for Postpartum Depression: A Secondary Analysis of New York City PRAMS Data. Int. J. Environ. Res. Public Health 2020, 17, 9328. DOI: 10.3390/ijerph17249328
42. Rai, S.; Pathak, A.; Sharma, I. Postpartum Psychiatric Disorders: Early Diagnosis and Management. Indian J. Psychiatry 2015, 57(Suppl 2), S216-S221. DOI: 10.4103/0019-5545.161481
43. Manso-Córdoba, S.; Pickering, S.; Ortega, M.A.; Asúnsolo, Á.; Romero, D. Factors Related to Seeking Help for Postpartum Depression: A Secondary Analysis of New York City PRAMS Data. Int. J. Environ. Res. Public Health 2020, 17, 9328.
44. Committee on Diagnostic Error in Health Care; Board on Health Care Services; Institute of Medicine; The National Academies of Sciences, Engineering, and Medicine; Balogh, E. P.; Miller, B. T.; Ball, J. R. Improving Diagnosis in Health Care. National Academies Press: Washington, DC, 2015.
45. Altamura, M.; Leccisotti, I.; De Masi, L.; Gallone, F.; Ficarella, L.; Severo, M.; Biancofiore, S.; Ventriglio, A.; Petito, A.; Maruotti, G.; Nappi, L. Coping as a Mediator between Attachment and Depression either in Pregnancy or in the Early Postpartum Period: A Structural Equation Modelling Approach.
46. Valverde, N.; Mollejo, E.; Legarra, L.; Gómez-Gutiérrez, M. Psychodynamic Psychotherapy for Postpartum Depression: A Systematic Review. Matern. Child Health J. 2023.
47. Hofmann, S. G.; Asnaani, A.; Vonk, I. J.; Sawyer, A. T.; Fang, A. The Efficacy of Cognitive Behavioral Therapy: A Review of Meta-Analyses. Cognit. Ther. Res. 2012, 36, 427-440.
48. Rajhans, P.; Hans, G.; Kumar, V.; Chadda, R. K. Interpersonal Psychotherapy for Patients with Mental Disorders. Indian J. Psychiatry 2020, 62 (Suppl 2), S201-S212.
49. Hofmann, S. G.; Gómez, A. F. Mindfulness-Based Interventions for Anxiety and Depression. Psychiatr. Clin. North Am. 2017, 40, 739-749. DOI: 10.1016/j.psc.2017.08.008.
50. Xie, Y.; Wu, Z.; Sun, L.; Zhou, L.; Wang, G.; Xiao, L.; Wang, H. The Effects and Mechanisms of Exercise on the Treatment of Depression. Front. Psychiatry 2021, 12, 705559.
51. Goodrich, D. E.; Kilbourne, A. M.; Nord, K. M.; Bauer, M. S. Mental Health Collaborative Care and Its Role in Primary Care Settings. Curr. Psychiatry Rep. 2013, 15, 383.
52. Fitelson, E.; Kim, S.; Baker, A. S.; Leight, K. Treatment of Postpartum Depression: Clinical, Psychological and Pharmacological Options. Int. J. Womens Health 2010, 3, 1-14.
53. Chu, A.; Wadhwa, R. Selective Serotonin Reuptake Inhibitors. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023.
54. Desorcy-Scherer, K.; Fricke, H. P.; Hernandez, L. L. Selective Serotonin Reuptake Inhibitors During Pregnancy and Lactation: A Scoping Review of Effects on the Maternal and Infant Gut Microbiome. Dev. Psychobiol. 2024, 66(1), e22441.
55. Schatzberg, A. F.; Mathew, S. J. The Why, When, Where, How, and So What of So-Called Rapidly Acting Antidepressants. Neuropsychopharmacology 2024, 49(1), 189-196.
56. Oracz, A.; Modzelewski, S.; I?endo, K.; Sokó?, A. Brexanolone and Current Methods of Treating Postpartum and Perinatal Depression. Pharmacother. Psychiatry Neurol./Farmakoterapia Psychiatrii Neurologii 2023, 39(1), 53-64.
57. Benevent, J.; Araujo, M.; Karki, S.; Delarue-Hurault, C.; Waser, J.; Lacroix, I.; Tebeka, S.; Damase-Michel, C. Risk of Hypertensive Disorders of Pregnancy in Women Treated With Serotonin-Norepinephrine Reuptake Inhibitors: A Comparative Study Using the EFEMERIS Database. J. Clin. Psychiatry 2023, 84(4), 47872.
58. Dama, M. H.; Van Lieshout, R. J. Perinatal Depression: A Guide to Detection and Management in Primary Care. J. Am. Board Fam. Med. 2023, 36(6), 1071–1086.
59. López-Muñoz, F. Commentary on The Discovery of Tricyclic Antidepressants and Their Mode of Action by F. Sulser and R. Mishra. In Discoveries in Pharmacology; Editor(s), Ed(s).; Academic Press: Place of Publication, 2023; pp 153-159.
60. Clayton, A. H.; Deligiannidis, K. M.; Ramos-Quiroga, J. A.; Lasser, R.; Sankoh, A. J.; Leclair, B.; Kotecha, M.; Doherty, J. Rapid Improvements in MADRS with Zuranolone in Major Depressive Disorder and Postpartum Depression: Results from the LANDSCAPE/NEST Clinical Development Programmes. Eur. Psychiatry 2023, 66(S1), S93-S94.
61. Hend Abdelbary Ibrahim Aly. "Diagnosis and management of Postpartum Depression." J. Psychiatry Psychiatric Disorders 2023, 7, 25–.
62. Gabriel, F. C.; Stein, A. T.; Melo, D. d. O.; Fontes-Mota, G. C. H.; dos Santos, I. B.; Rodrigues, C. d. S.; et al. Guidelines’ Recommendations for the Treatment-Resistant Depression: A Systematic Review of Their Quality. PLoS ONE 2023, 18(2), e0281501.
63. Bodoano Sanchez, I.; Mata Agudo, A.; Guerrero-Jiménez, M.; Girela Serrano, B.; Alvarez Gil, P.; Carrillo de Albornoz Calahorro, C. M.; Gutiérrez-Rojas, L. Treatment of Post-Psychotic Depression in First-Episode Psychosis: A Systematic Review. Nord. J. Psychiatry 2023, 77(2), 109-117.
64. Okun, M. L.; Lac, A. Postpartum Insomnia and Poor Sleep Quality Are Longitudinally Predictive of Postpartum Mood Symptoms. Psychosom. Med. 2023, 85(8), 736-743.
65. Cardoso, C.; Fonseca, A. Mothers At-Risk for Postpartum Depression: Mental Health and Emotion Regulation Throughout the Postpartum Period. Curr. Psychol. 2023, 42(15), 12988-13002.
66. Malloy-Diniz, L. F.; Bonney-Helliwell, M.; Joaquim, R. M.; Elliott, G. K. The Utilization of Cultural Movements to Overcome Stigma in Narrative of Postnatal Depression. In Stigma's Impact on People With Mental Illness: Advances in Understanding, Management, and Prevention; Editor(s), Ed(s).; Publisher: Place of Publication, 2021; Sep 13.
67. Cardoso, C.; Fonseca, A. Mothers at-Risk for Postpartum Depression: Mental Health and Emotion Regulation Throughout the Postpartum Period. Curr. Psychol. 2023, 42(15), 12988–13002.
68. Walls, J.; Leiferman, J. A.; Farewell, C. V.; Lacy, R. Postpartum Depression: Overcoming Mental Health Challenges during Parenthood. Health 2023, 15(7), 728-745.